FR2445M - Nouveaux dérivés de la pipérazine, utilisables en thérapeutique. - Google Patents

Nouveaux dérivés de la pipérazine, utilisables en thérapeutique.

Info

Publication number
FR2445M
FR2445M FR925898A FR925898A FR2445M FR 2445 M FR2445 M FR 2445M FR 925898 A FR925898 A FR 925898A FR 925898 A FR925898 A FR 925898A FR 2445 M FR2445 M FR 2445M
Authority
FR
France
Prior art keywords
usable
therapy
piperazine derivatives
new piperazine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR925898A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Original Assignee
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7429/62A external-priority patent/GB984017A/en
Application filed by Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA filed Critical Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Application granted granted Critical
Publication of FR2445M publication Critical patent/FR2445M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR925898A 1962-02-26 1963-02-25 Nouveaux dérivés de la pipérazine, utilisables en thérapeutique. Active FR2445M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7429/62A GB984017A (en) 1962-02-26 1962-02-26 New piperazine derivatives and a process for their preparation
GB4009662 1962-10-23

Publications (1)

Publication Number Publication Date
FR2445M true FR2445M (fr) 1964-04-06

Family

ID=87519722

Family Applications (1)

Application Number Title Priority Date Filing Date
FR925898A Active FR2445M (fr) 1962-02-26 1963-02-25 Nouveaux dérivés de la pipérazine, utilisables en thérapeutique.

Country Status (1)

Country Link
FR (1) FR2445M (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2535718A1 (fr) * 1982-11-09 1984-05-11 Sanofi Sa (piperazinyl-1)-2 pyrimidines, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2535718A1 (fr) * 1982-11-09 1984-05-11 Sanofi Sa (piperazinyl-1)-2 pyrimidines, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant
EP0115713A1 (fr) * 1982-11-09 1984-08-15 Sanofi S.A. (Pipérazinyl-1)-2 pyrimidines, leurs sels, procédé pour leur préparation et compositions pharmaceutiques en contenant

Similar Documents

Publication Publication Date Title
FR3380M (fr) Nouvelles préparations anthelmintiques, utilisables en thérapeutique.
FR3257M (fr) 4,4-bioxyde de la 1-(5-nitrofurfurylidene-amino)-1,4-tétrahydrothiazine.
FR1749M (fr) Nouveaux dérivés de la pipérazine, utilisables en thérapeutique.
FR2445M (fr) Nouveaux dérivés de la pipérazine, utilisables en thérapeutique.
FR2446M (fr) Nouveaux dérivés de la pipérazine.
FR3137M (fr) Nouvel δ<4>-7α, 17α-diméthyl-17β-hydroxy-oestrene utilisable en thérapie.
FR2936M (fr) Dérivés de la pipérazine.
FR2229M (fr) Dérivés de la pyrazine utilisables comme médicaments.
FR2797M (fr) Nouveaux dérivés de pipéridine.
FR3138M (fr) Nouveaux dérivés de la 6-11-dihydrodibenz/b, e/thiépine.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR1823M (fr) Dérivés de la cynarine.
ES148615Y (es) Mesa plegable, perfeccionada.
FR2114M (fr) Nouveaux dérivés alkylsulfonyloxy utilisables comme médicaments.
FR2799M (fr) Nouvelles β-phénylcyclohexylamines substituées utiles en thérapeutiques.
FR1728M (fr) Médicament gastro-entérologique.
FR1739M (fr) Médicament gastro-entérologique.
FR3761M (fr) Nouvelles dihydrothiéno-[3,4-d]-pyrimidines.
ES160769Y (es) Carro-cesta, perfeccionado.
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
FR2873M (fr) Nouvelle préparation anthelmintique, utilisable en thérapeutique.
ES90836Y (es) Faja-braga perfeccionada.
ES95190Y (es) Figura de adorno, perfeccionada
BE618690A (fr) Chaise roulante.
ES147727Y (es) Sauna perfeccionada.